CAR-T CELL THERAPY IN ACUTE LEUKEMIAS
Acute leukemias, particularly acute lymphoblastic leukemia (ALL) and, to a lesser extent, acute myeloid leukemia (AML), remain among the most challenging hematologic malignancies due to high mortality rates and limited treatment options. In this context, Chimeric Antigen Receptor T (CAR-T) cell ther...
Saved in:
| Main Author: | Serhat Çelik |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137924029456 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
by: Ugo Testa, et al.
Published: (2024-01-01) -
Diagnostic approach to the evaluation of myeloid malignancies following CAR T-cell therapy in B-cell acute lymphoblastic leukemia
by: Aimee C Talleur, et al.
Published: (2020-10-01) -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
by: Ugo Testa, et al.
Published: (2024-04-01) -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
by: Eugenio Galli, et al.
Published: (2024-02-01) -
Dual-targeting CAR T cells for B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma
by: Gustavo de Oliveira Canedo, et al.
Published: (2025-02-01)